VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Jul 11, 2024 8:53am

82 Views

Post# 36127946

Congratulations to the authors on this important article! 👏

Interesting !

Angio Consult GmbH reposted this

Leaflet modification is key for the lifetime management of patients requiring multiple valve interventions

Annual ViV is projected to reach ~42k US procedures in 2035 (~15% of all TAVR).

With increased TAVR usage, total annual TAVR-in-TAVR is expected to overtake TAVR-in-SAVR by 2028.

Congratulations to the authors on this important article!

https://lnkd.in/du6vHPmJ

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3